Lowest Price Guaranteed From USD 4,799
Incorporation of MES into production line can streamline material cost and time spent in production. I believe, MES has the potential to reduce 10%-30% of the overall production cost, depending on the type of industry
-- CEO, a small-sized company
The manufacturing execution system market / MES software market is estimated to be worth $3 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast period. Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at an annualized growth rate of 36%. However, it is important to consider that the constant management of such enormous volumes of data is a tedious and challenging process. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialized personnel. According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers. The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources. Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES).
In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. In addition, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volume of data from various sources, as well as to produce value in the form of insights, predictions and actions. According to industry experts, manufacturing execution systems has the potential to reduce 10%-30% of the overall production cost depending on the type of industry. It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses. Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promotes collaboration. Considering the rising demand for such systems, presently, more than 75 companies claim to offer manufacturing execution systems, based on several deployment models, to the healthcare sector. It is worth mentioning that, in the past few years, substantial acquisition activity has been reported in the manufacturing execution system market, as players strive to become one-stop-shops, to cater to the diverse needs of the healthcare sector. Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive market growth over the forecast period.
Key Companies in Manufacturing Execution System Market / MES Platforms Market
Examples of key companies engaged in manufacturing execution system market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Andea, Critical Manufacturing, Dassault Systèmes, GE Digital, Infor, Körber and Rockwell Automation. This market report includes an easily searchable excel database of all the manufacturing execution system companies serving the healthcare industry, worldwide.
Recent Developments in Manufacturing Execution System Market
Several recent developments have taken place in the field of manufacturing execution system market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The “Manufacturing Execution System Market in Healthcare by Type of Deployment (Cloud, Corporate Datacenter, Hybrid and On Premise), Type of End-User (Life science / Biotechnology Companies, Medical Device Providers, Pharmaceutical Companies and Others) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” market report features an extensive study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities for players engaged in offering manufacturing execution systems in the healthcare sector. The market research report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in manufacturing execution system market. Amongst other elements, the market report features.
A general introduction to manufacturing execution systems, along with information on their core functions. Additionally, it includes details on the various deployment models adopted by providers. Further, it features a brief discussion on the key advantages and disadvantages associated with manufacturing execution systems in the healthcare sector.
The key objective of manufacturing execution system market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for manufacturing execution system market during the forecast period. Additionally, the market report features the likely distribution of the current and forecasted opportunity across [A] type of deployment (cloud, corporate datacenter, hybrid and on premise), [B] type of end-user (life science / biotechnology companies, medical device providers, pharmaceutical companies and others), and [C] key geographical regions (North America, Europe, Asia, Middle East and North Africa, Latin America and Rest of the World). In order to account for future uncertainties and add robustness to our forecast model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
A collection of interview transcripts of discussions held with key stakeholders in this industry. In this chapter, we have presented the details of our conversations held with Carine van Godtsenhoven (Chief Marketing Officer, ORDINAL Software), Philip Borland (Chief Executive Officer, NoMuda), Yaron Halfon (Director of Sales, Trunovate).